Clinical relevance of proteomic profiling in de novo pediatric acute myeloid leukemia: a Children’s Oncology Group study

Pediatric acute myeloid leukemia (AML) remains a fatal disease for at least 30% of patients, stressing the need for improved therapies and better risk stratification. As proteins are the unifying feature of (epi)genetic and environmental alterations, and are often targeted by novel chemotherapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoff, Fieke W., van Dijk, Anneke D., Qiu, Yihua, Hu, Chenyue W., Ries, Rhonda E., Ligeralde, Andrew, Jenkins, Gaye N., Gerbing, Robert B., Gamis, Alan S., Aplenc, Richard, Kolb, E. Anders, Alonzo, Todd A., Meshinchi, Soheil, Qutub, Amina A., de Bont, Eveline S.J.M., Horton, Terzah M., Kornblau, Steven M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Article - Acute Myeloid Leukemia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521248/
https://www.ncbi.nlm.nih.gov/pubmed/35021602
http://dx.doi.org/10.3324/haematol.2021.279672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521248/
https://www.ncbi.nlm.nih.gov/pubmed/35021602
http://dx.doi.org/10.3324/haematol.2021.279672

Ejemplares similares